Aug 14, 2020
Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
May 14, 2020
binx health Announces Publication of Pivotal Study in JAMA Network Open
May 04, 2020
Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis
Apr 30, 2020
binx health Announces Second FDA 510(k) Clearance Of Its Molecular Point-Of-Care Infectious Disease Platform
Apr 28, 2020
Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020
Jan 14, 2020
Nurx Introduces Convenient & Stigma-Free Treatment for Herpes
Dec 18, 2019
U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy
Dec 03, 2019
PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora®
Nov 26, 2019
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora® for the Prevention of Pregnancy
Nov 13, 2019
Evofem Biosciences to Participate in Upcoming Investor Conferences
Oct 08, 2019
Fifth-straight year of STD increases demands urgent action
Sep 25, 2019
Evofem Biosciences to Present at Cantor Global Healthcare Conference on October 4, 2019
Sep 18, 2019
If you could get a vaccination that would prevent cancer - would you?
Aug 26, 2019
Evofem Biosciences Completes Phase 2b 'AMPREVENCE' Trial of Amphora for Prevention of Chlamydia and Gonorrhea in Women
Aug 22, 2019
Evofem Biosciences to Present at Upcoming Healthcare Conferences
Aug 20, 2019
Soaring Sales of Azithromycin Influencing Gonorrhea Therapeutics Market Growth, Reports Fact.MR
Aug 12, 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Aug 05, 2019
The global sexually transmitted disease testing market at a CAGR of almost 9% during the forecast period
Jul 30, 2019
Evofem Biosciences to Report Second Quarter 2019 Results and Provide Corporate Update on August 6, 2019
Jul 23, 2019
BlueWillow Biologics Awarded Patent for Intranasal Genital Herpes Vaccine